Addiction Medications
- Probuphine
Probuphine (buprenorphine) implant for subdermal administration (CIII) is indicated for the maintenance treatment of opioid dependence in patients who have achieved and sustained prolonged clinical stability on low-to-moderate doses of a transmucosal buprenorphine-containing product.
- Vivitrol
Vivitrol (naltrexone for extended-release injectable suspension) is indicated for the treatment of alcohol dependence in patients who are able to abstain from alcohol in an outpatient setting prior to initiation of treatment with Vivitrol.
- Bunavail
Bunavail (buprenorphine and naloxone) buccal film (CIII) is a prescription medicine indicated for the maintenance treatment of opioid dependence. Bunavail should be used as part of a complete treatment plan including counseling and psychosocial support.
- Zubsolv
Zubsolv (buprenorphine and naloxone) sublingual tablets for sublingual administration (CIII) is a partial opioid agonist indicated for treatment of opioid dependence. Prescription use of this project is limited under the Drug Addiction Treatment Act.
- Suboxone
Suboxone (buprenorphine and naloxone) Sublingual Film (CIII) is a prescription medicine indicated for treatment of opioid dependence and should be used as part of a complete treatment plan including counseling and psychosocial support.
For more information, do not hesitate to call us at 618-233-0100. We are more than happy to assist you with drug-related concerns.